受强制性开放获取政策约束的文章 - Adrian Sacher了解详情
无法在其他位置公开访问的文章：13 篇
Biomarkers for the clinical use of PD-1/PD-L1 inhibitors in non–small-cell lung cancer: a review
AG Sacher, L Gandhi
JAMA oncology 2 (9), 1217-1222, 2016
强制性开放获取政策： Canadian Institutes of Health Research
BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancer
R Shi, SN Martins Filho, M Li, A Fares, J Weiss, NA Pham, O Ludkovski, ...
Lung Cancer 146, 78-85, 2020
强制性开放获取政策： Canadian Cancer Society, Canadian Institutes of Health Research
Next-generation sequencing informs diagnosis and identifies unexpected therapeutic targets in lung squamous cell carcinomas
JM Sands, T Nguyen, P Shivdasani, AG Sacher, ML Cheng, RS Alden, ...
Lung Cancer 140, 35-41, 2020
强制性开放获取政策： Canadian Institutes of Health Research
New drugs for brain tumors? Insights from chemical probing of neural stem cells
P Diamandis, AG Sacher, M Tyers, PB Dirks
Medical hypotheses 72 (6), 683-687, 2009
强制性开放获取政策： Howard Hughes Medical Institute, Canadian Institutes of Health Research …
Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy
GM Boukhaled, R Gadalla, HJ Elsaesser, D Abd-Rabbo, R Quevedo, ...
Nature immunology 23 (8), 1273-1283, 2022
强制性开放获取政策： US National Institutes of Health, Canadian Cancer Society, Canadian …
Real-world treatment sequencing, toxicities, health utilities, and survival outcomes in patients with advanced ALK-rearranged non-small-cell lung cancer
S Schmid, S Cheng, S Chotai, M Garcia, L Zhan, K Hueniken, ...
Clinical lung cancer 24 (1), 40-50, 2023
强制性开放获取政策： Swiss Cancer Foundation
Systemic Inflammatory Markers of Survival in Epidermal Growth Factor–Mutated Non–Small-Cell Lung Cancer: Single-Institution Analysis, Systematic Review, and Meta-analysis
SWS Chan, E Smith, R Aggarwal, K Balaratnam, RQ Chen, K Hueniken, ...
Clinical Lung Cancer 22 (5), 390-407, 2021
强制性开放获取政策： Canadian Cancer Society
Chemical genetics screen identifies COPB2 tool compounds that alters ER stress response and induces RTK dysregulation in lung cancer cells
P Saraon, J Snider, W Schormann, A Rai, N Radulovich, ...
Journal of molecular biology 433 (23), 167294, 2021
强制性开放获取政策： Canadian Cancer Society, Canadian Institutes of Health Research, Genome …
Treatment patterns and outcomes in early-stage ALK-rearranged non-small cell lung cancer
S Schmid, M Garcia, S Cheng, L Zhan, S Chotai, K Balaratnam, K Khan, ...
Lung Cancer 166, 58-62, 2022
强制性开放获取政策： Swiss Cancer Foundation
EGFR-mutated lung adenocarcinomas from patients who progressed on EGFR-inhibitors show high engraftment rates in xenograft models
SN Martins-Filho, J Weiss, NA Pham, Q Li, M Cabanero, A Fares, ...
Lung Cancer 145, 144-151, 2020
强制性开放获取政策： Canadian Cancer Society, Canadian Institutes of Health Research
Early detection of multiple resistance mechanisms by ctDNA profiling in a patient with EGFR-mutant lung adenocarcinoma treated with osimertinib
S Schmid, EL Stewart, SN Martins-Filho, M Cabanero, A Wang, H Bao, ...
Clinical Lung Cancer 21 (5), e488-e492, 2020
强制性开放获取政策： Swiss Cancer Foundation
Treatment patterns and outcomes of patients with advanced pleural mesothelioma at an academic referral centre
S Schmid, L Zhan, K Dietrich, K Khan, M Chowdhury, M Herman, D Patel, ...
Clinical Lung Cancer 23 (1), e43-e53, 2022
强制性开放获取政策： Swiss Cancer Foundation
Immediate Versus Deferred Systemic Therapy in Patients With Mesothelioma
S Schmid, L Zhan, M Garcia, K Dietrich, K Khan, M Chowdhury, ...
Clinical lung cancer, 2024
强制性开放获取政策： Swiss Cancer Foundation
可在其他位置公开访问的文章：26 篇
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors
DS Hong, MG Fakih, JH Strickler, J Desai, GA Durm, GI Shapiro, ...
New England Journal of Medicine 383 (13), 1207-1217, 2020
强制性开放获取政策： US National Institutes of Health, Damon Runyon Cancer Research Foundation …
Sotorasib for Lung Cancers with KRAS p.G12C Mutation
F Skoulidis, BT Li, GK Dy, TJ Price, GS Falchook, J Wolf, A Italiano, ...
New England Journal of Medicine 384 (25), 2371-2381, 2021
强制性开放获取政策： US National Institutes of Health
Prospective validation of rapid plasma genotyping for the detection of EGFR and KRAS mutations in advanced lung cancer
AG Sacher, C Paweletz, SE Dahlberg, RS Alden, A O’Connell, N Feeney, ...
JAMA oncology 2 (8), 1014-1022, 2016
强制性开放获取政策： US National Institutes of Health, Canadian Institutes of Health Research
Bias-corrected targeted next-generation sequencing for rapid, multiplexed detection of actionable alterations in cell-free DNA from advanced lung cancer patients
CP Paweletz, AG Sacher, CK Raymond, RS Alden, A O'Connell, SL Mach, ...
Clinical Cancer Research 22 (4), 915-922, 2016
强制性开放获取政策： US National Institutes of Health
Association between younger age and targetable genomic alterations and prognosis in non–small-cell lung cancer
AG Sacher, SE Dahlberg, J Heng, S Mach, PA Jänne, GR Oxnard
JAMA oncology 2 (3), 313-320, 2016
强制性开放获取政策： US National Institutes of Health, Canadian Institutes of Health Research
Identification of a bone marrow–derived epithelial-like population capable of repopulating injured mouse airway epithelium
AP Wong, A Keating, WY Lu, P Duchesneau, X Wang, A Sacher, J Hu, ...
The Journal of clinical investigation 119 (2), 336-348, 2009
强制性开放获取政策： Canadian Institutes of Health Research
Acquired METD1228V Mutation and Resistance to MET Inhibition in Lung Cancer
M Bahcall, T Sim, CP Paweletz, JD Patel, RS Alden, Y Kuang, AG Sacher, ...
Cancer discovery 6 (12), 1334-1341, 2016
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定